Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Spinnovation Introduces New Elemental and Trace Metals Analysis

Published: Tuesday, November 05, 2013
Last Updated: Tuesday, November 05, 2013
Bookmark and Share
New Elemental Analysis for cell culture media and raw materials.

To offer a more complete analysis platform for cell culture, Spinnovation has introduced new Elemental Analysis for cell culture media and raw materials.

Elemental Analysis uses Inductively Coupled Plasma-Optical Emission Spectroscopy (ICP-OES) to test samples for up to 30 elements and trace metals, at levels as low as parts per billion (ppb).

With this service Spinnovation enables customers to characterize raw materials and monitor the elements critical to cells, for maximum cell culture production yield and optimal performance.

Elemental Analysis is a flexible custom analysis service, tailored to clients’ needs. Each customer may select the elements to be monitored in groups of up to 25.

Elemental Analysis can be used to monitor both standard and trace level elements. Analysis is charged competitively on a pay-per-sample basis.

Moreover, Spinnovation provides quick turnaround, with results typically delivered within 10 business days. This new offering complements the analysis packages already available at Spinnovation to develop troubleshoot and monitor bioprocess, including Spedia-NMR™, vitamin analysis and different raw material profiling assays.

Frederic Girard, CEO of Spinnovation Analytical, said, “Elemental Analysis adds to our advanced cell culture analysis offering, by allowing customers to quickly assess levels of elements vital to cell growth in cultures and to troubleshoot bioprocess performance variability. Together with Spedia-NMR™ for upstream processing and Spedia-Predict™ for achieving optimal and consistent bio-manufacturing performance, Elemental Analysis will allow us to meet all the needs of customers in the biologics field.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More than 4,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Spinnovation Transfers its Entire Operation to Pivot Park
The new location has enabled Spinnovation to double the size of its facilities, to support the growth of its business.
Monday, January 13, 2014
CEO Frederic Girard Joins Fellow Industry Experts for a QbD Round Table
New article on quality by design is now available online.
Friday, August 16, 2013
Spinnovation Expands in to the US
Spinnovation collaborate with Quantum Tessera in Pennsylvania.
Tuesday, April 17, 2012
Scientific News
Disrupting Tumour-Promotion in Humans
Researchers have modified an existing protein to represses a specific cancer-promoting ‘message’ within cells.
Protein Nanocages Could Improve Drug Design and Delivery
HHMI scientists have designed and built 10 large protein icosahedra that are similar to viral capsids that carry viral DNA.
Vaccine Strategy Targets Multiple Influenza Viruses
Scientists have identified vaccine-induced antibodies that can neutralize strains of influenza virus that infect humans.
Antibody-Based Drug for Multiple Sclerosis
New antibody-based drug paves the way for new strategies for controlling and treating multiple sclerosis.
Structure of Cold Virus Solved
Researchers have identified the structure of an elusive cold virus linked to child asthma and respiratory infections, providing the foundation for treating the virus.
'Poison Pill' Fed to Deadly Virus
Researchers have created a genetic modification within a virus (with funny name), rendering it unable to replicate, mutate or cause illness.
World First Alzheimer's Vaccine Breakthrough
Researchers have made a breakthrough discovery towards an effective vaccine for Alzheimer's by targeting associated proteins.
Immunotherapy Drug Combo Targets Cancer
Mayo Clinic researchers identify potential immunotherapy drug combination that shows therapeutic effects against advanced and metastatic cancers.
Study Shows Sandoz Biosimilar Equivalent to Originator Drug
New data shows Sandoz biosimilar candidate has equivalent efficacy to originator etanercept following comparison in psoriasis.
Biomunex Confirms Optimal Properties and Activity of BiXAb® Antibodies
Biomunex‘s Plug-and-Play bispecific antibodies demonstrated excellent in vitro properties and in vivo activity positively differentiating their BiXAb platform from competing formats.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!